The Duke Baerveldt 350 Versus Ahmed ClearPath 350 Study (DBACS): A Randomized Control Trial In Adults With Medically Refractory Glaucoma.

Clin Ophthalmol · 2025 · PMC12452963 · PMID 40989068

Europe PMC DOI

hedged sentences

0.0560

closest p · 1.1× alpha

0.0790

boldest claim

The sentences

approached significancep = 0.056so close (0.05 < p ≤ 0.1)

Notably, however, the differences in the distribution of glaucoma diagnosis type approached significance, with primary open angle glaucoma comprising a larger portion of the ACP group (97.4% in ACP vs 78.8% in BVT, p = 0.056).

also in 5,257 other papers

approaching significancep = 0.079so close (0.05 < p ≤ 0.1)

No statistical difference in medications was seen at each time point afterwards; however, month 12 was approaching significance in favor of less medications for ACP group (2.3 ± 1.2 vs 1.6 ± 1.5, p = 0.079).

also in 1,608 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.